Lion Biotechnologies, Inc. (LBIO)
NGM · Common · CUSIP 53619R102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LBIO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
53619R102
Market Cap
Small Cap · $379 Million
IPO
2/26/2015 · $8.00/share
Business: Lion Biotechnologies, Inc. is a biotechnology company that is focused on developing and commercializing adoptive cell therapy (ACT) using autologous tumor infiltrating lymphocytes for the treatment of metastatic melanoma and other solid cancers.

Company Contact

CEO
Elma S. Hawkins Ph.D.
CFO
Michael Handelman
Headquarters
21900 Burbank Boulevard, Third Floor, Woodland Hills, CA 91367
Phone
818-992-3126
Investor Relations
Tricia Truehart, The Trout Group · 646-378-2953 · ttruehart@troutgroup.com
SEC EDGAR Filings
View filings »